bone loss semaglutide (Ozempic) linked to fewer fractures despite greater weight Semaglutide linked to lower bone

However, medication condition was not associated with time to initiating drinking in the paradigm

I recently learned about retatrutide through an acquaintance a recreational weightlifter whos been selfadministering this investigational triple G peptide (mimicking GLP1, GIP, and glucagon)

Those included: Nausea (about 29 to 42 percent of participants, depending on the dose) Diarrhea (25 to 34 percent) Constipation (24 to 26 percent) Vomiting (11 to 25 percent) Upper respiratory tract infection (12 to 14 percent) Interestingly, more people taking a placebo dropped out of the trial because of side effects than participants taking the lowest dose of retatrutide (4.9 percent compared with 4.1 percent)

By reducing the oxidative burden on these vascular cells, Liposomal Glutathione helps to restore normal endothelial function

Sci Rep 2024